From Academic Roots to Global Leadership

Founded in 1999 out of King’s College London, MedPharm’s goal was to revolutionize topical and transdermal drug development. Since its inception, MedPharm has built a reputation as a trusted CDMO partner, providing formulation development, analytical services, and manufacturing solutions that help clients navigate the complexities of drug development.

Expanding Our Global Footprint

Through scientific integrity, innovation, and rigor at our foundation, MedPharm has grown into a global leader with state-of-the-art facilities in Guildford, UK, and Durham, North Carolina, USA. Our investment in cutting-edge research and manufacturing capabilities has solidified MedPharm as the go-to CDMO for dermatological, respiratory, ophthalmic, ungual, mucosal, and transdermal product development.  From concept all the way to commercial product, MedPharm can take you there. 

Driving Innovation & Delivering Results

Over the past 25 years, MedPharm has contributed to developing and approving over 85 marketed products across the USA, Europe, and Japan. Our expertise and proprietary technologies—such as MedSpray®—help clients de-risk development, attract investment, and accelerate regulatory approvals. 

By integrating scientific excellence, automation, and industry-leading expertise, MedPharm continues to push the boundaries of topical and transdermal drug delivery—helping clients transform novel formulations into successful, patient-centric therapies.